These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23078345)

  • 21. Sunitinib-aggravated hypertension.
    Rivera F; Benounna M; Sánchez de la Nieta MD
    J Hypertens; 2009 Jul; 27(7):1502-3. PubMed ID: 19542988
    [No Abstract]   [Full Text] [Related]  

  • 22. Sunitinib and Thrombosis.
    Lamba G; Deol R; Shah D; Sahni R; Malhotra BK
    J Gastrointest Cancer; 2012 Sep; 43 Suppl 1():S128-30. PubMed ID: 21881834
    [No Abstract]   [Full Text] [Related]  

  • 23. Cardiotoxicity associated with sunitinib.
    Hariharan S; Lowry S
    Lancet; 2008 Apr; 371(9620):1244-5; author reply 1245. PubMed ID: 18406854
    [No Abstract]   [Full Text] [Related]  

  • 24. Sunitinib-induced subungual splinter haemorrhage and acral erythema.
    Nakamura M; Miyachi Y
    Eur J Dermatol; 2008; 18(3):344-5. PubMed ID: 18474471
    [No Abstract]   [Full Text] [Related]  

  • 25. "Pseudocavitation" in thymic carcinoma during treatment with sunitinib.
    Tiseo M; Rajan A; Thomas A; Giaccone G
    J Thorac Oncol; 2013 Apr; 8(4):511-2. PubMed ID: 23486269
    [No Abstract]   [Full Text] [Related]  

  • 26. Eruptive melanocytic nevi in a patient undergoing treatment with sunitinib.
    Jiménez-Gallo D; Albarrán-Planelles C; Linares-Barrios M; Martínez-Rodríguez A; Báez-Perea JM
    JAMA Dermatol; 2013 May; 149(5):624-6. PubMed ID: 23677103
    [No Abstract]   [Full Text] [Related]  

  • 27. Acute cardiac failure after sunitinib.
    Machiels JP; Bletard N; Pirenne P; Jacquet L; Bonbled F; Duck L
    Ann Oncol; 2008 Mar; 19(3):597-9. PubMed ID: 18272908
    [No Abstract]   [Full Text] [Related]  

  • 28. Sunitinib-associated thrombotic microangiopathy: a significant risk.
    Buckley FD; Preston G; Meiklejohn DJ; Adamson D
    Clin Oncol (R Coll Radiol); 2014 Aug; 26(8):515. PubMed ID: 24746506
    [No Abstract]   [Full Text] [Related]  

  • 29. Sunitinib-induced hemoglobin changes are related to the dosing schedule.
    van der Veldt AA; Boven E; Vroling L; Broxterman HJ; van den Eertwegh AJ; Haanen JG
    J Clin Oncol; 2009 Mar; 27(8):1339-40; author reply 1340-2. PubMed ID: 19188672
    [No Abstract]   [Full Text] [Related]  

  • 30. Unanswered questions regarding the management of sunitinib-induced hypothyroidism.
    Garfield D; Hercbergs A; Davis P
    Nat Clin Pract Oncol; 2007 Dec; 4(12):674. PubMed ID: 17955044
    [No Abstract]   [Full Text] [Related]  

  • 31. Macrocytosis and cobalamin deficiency in patients treated with sunitinib.
    Gillessen S; Graf L; Korte W; Cerny T
    N Engl J Med; 2007 May; 356(22):2330-1. PubMed ID: 17538098
    [No Abstract]   [Full Text] [Related]  

  • 32. Reversible posterior leukoencephalopathy syndrome induced by sunitinib.
    Martín G; Bellido L; Cruz JJ
    J Clin Oncol; 2007 Aug; 25(23):3559. PubMed ID: 17687168
    [No Abstract]   [Full Text] [Related]  

  • 33. Pyoderma gangrenosum with the use of sunitinib.
    Nadauld LD; Miller MB; Srinivas S
    J Clin Oncol; 2011 Apr; 29(10):e266-7. PubMed ID: 21220606
    [No Abstract]   [Full Text] [Related]  

  • 34. Tolerance of sunitinib in dialyzed patients with metastatic renal cell carcinoma.
    Vickers MM; Heng DY; Hemmelgarn B; Eigl BJ
    Clin Genitourin Cancer; 2009 Oct; 7(3):E104-6. PubMed ID: 19815480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cutaneous side effects of antiangiogenic agents].
    Robert C
    Bull Cancer; 2007 Jul; 94 Spec No():S260-4. PubMed ID: 17846013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sunitinib-induced hand-foot syndrome in a renal cell carcinoma: a sclerodermatous and rheumatoid arthritis-like case.
    Ohtsuka T
    J Dermatol; 2012 Nov; 39(11):943-4. PubMed ID: 22257303
    [No Abstract]   [Full Text] [Related]  

  • 37. How does sunitinib cause hypothyroidism?
    Hershman JM; Liwanpo L
    Thyroid; 2010 Mar; 20(3):243-4. PubMed ID: 20187779
    [No Abstract]   [Full Text] [Related]  

  • 38. Reversible cardiomyopathy associated with sunitinib and sorafenib.
    Uraizee I; Cheng S; Moslehi J
    N Engl J Med; 2011 Oct; 365(17):1649-50. PubMed ID: 22030001
    [No Abstract]   [Full Text] [Related]  

  • 39. A case of pyoderma gangrenosum possibly associated with sunitinib treatment.
    Ueharaguchi Y; Kabashima K; Sasahashi M; Matsuda A; Matubara K; Matsui M
    Int J Dermatol; 2013 May; 52(5):634-6. PubMed ID: 23590380
    [No Abstract]   [Full Text] [Related]  

  • 40. Lung Aspergillosis in renal cell carcinoma patient treated with sunitinib.
    Visvardis EE; Gao F; Paes MN; Duprez O; Waxman J
    QJM; 2012 Jul; 105(7):689-92. PubMed ID: 21693543
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.